DIM FAQ
 

 

Active Clinical Trials:

1. An Investigation into the Effects of Diindolylmethane (BioResponse DIM®) Supplementation in Women with Low-Grade Cervical Cytological Abnormalities.
Cancer Research UK
Click Here to Read the Article
Click Here to See Additional Information

2. Diindolylmethane in Healthy Volunteers: Multi Dose Study
University of Kansas

3. Diindolylmethane in Treating Patients With Abnormal Cervical Cells
Barts and the London School of Medicine
London, UK

4. Oral Diindolylmethane (DIM) for the Treatment of Cervical Dysplasia
Sponsor: NYU, New York Downtown Hospital
New York, NY

5. An Open Label Pilot Trial of BioResponse-DIM for the Treatment of Anal Human Papillomavirus Infection
Cornell University,
New York, NY

6. Diindolylmethane in Treating Patients With Nonmetastatic Prostate Cancer That Has Not Responded To Previous Hormone Therapy
Barbara Ann Karmanos Cancer Institute, Wayne State University
Detroit, MI

7. Diindolylmethane in Treating Patients Undergoing Surgery for Stage I or Stage II Prostate Cancer
University of Wisconsin
Madison, WI

Please visit ClinicalTrials.gov for a listing of Clinical Trials using DIM.

 

New 2006 Research Abstracts:

 

All Research Abstracts:
Diindolylmethane and I3C

Jump to
these sections:

 

Please Click to Read Articles

 

 

 
         

Introduction | Table of Contents | The Authors | Published Articles | Published Abstracts | Order | Home